A growing body of evidence is shifting expert opinion toward supporting MS treatment during pregnancy, emphasizing ...

Trastuzumab deruxtecan plus pertuzumab outperformed standard-of-care therapy as first-line treatment for HER2-positive ...

In addition, mirvetuximab soravtansine (Elahere) was the first targeted therapy to demonstrate an improvement in OS in ...

CHICAGO -- The bispecific T-cell engager tarlatamab (Imdelltra) significantly prolonged survival in the second-line treatment ...

People around the world are set to benefit from new breakthroughs in AI-driven drug discovery to tackle previously untreatable diseases and transforming patient outcomes using British AI and research ...

New project to make the UK a leader in AI-drug discovery, as Imperial College also partners with the World Economic Forum on ...

Dietmar Berger, M.D., Ph.D., joined Gilead Sciences as chief medical of | Dietmar Berger became Gilead Sciences’ new chief ...

The benefits of 52-week biologic therapy on asthma control and lung function are observed in both never smokers and ...

As a mom to a child withhemophilia, stepping away from sports seemed to be the only way to keep him protected from a life-threatening bleed.

The pharmacy benefit manager (PBM) industry is under pressure to shift to models that avoid conflicts of interest and ...